http://www.noxopharmblog.com.au/march-2017-quarter-appendix-4c-follow-ceo-blog/
Extract:
Q: When will the Company know if NOX66 is working and when will the market hear about it?
A: Each of the studies has a series of in-built review points that will allow us to release news on a progressive basis. I have consistently said that I am confident that we (and therefore the market) will know before the end of this year whether or not NOX66 holds the promise that we believe it has. I don’t know of another ASX-listed biotech that could make such a claim within 15 months of listing.
In other words, clinical trial data will tell us, within six months, whether NOX66 is likely to be a blockbuster drug.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | 8.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 57000 | 1 |
View Market Depth
| Last trade - 09.59am 17/09/2025 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable